Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Perceptive Capital Solutions, Inc. (PCSC:NASDAQ), powered by AI.
Perceptive Capital Solutions, Inc. is currently trading at $11.95. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Perceptive Capital Solutions, Inc. on Alpha Lenz.
Perceptive Capital Solutions, Inc.'s P/E ratio is 157.9.
“Perceptive Capital Solutions, Inc. trades at a P/E of 157.9 (premium valuation) with modest ROE of 1.0%.”
Ask for details →Perceptive Capital Solutions, Inc. operates within the financial services sector, specializing in providing a variety of tailored capital solutions to healthcare and life sciences companies. The primary function of the company is to offer innovative financing options that support the growth and development of businesses in these critical sectors. This includes structured equity investments, credit facilities, and strategic financial advice, enabling companies to access necessary funds for research, development, and expansion. Perceptive Capital Solutions, Inc. plays a pivotal role in the economic landscape by supporting companies at different stages of their life cycle, from early-stage ventures to established enterprises. The firm is known for its deep sector expertise and long-term partnerships with healthcare innovators, reinforcing its significance in advancing technological and medical advancements through capital support. By leveraging a targeted investment approach, Perceptive Capital Solutions, Inc. contributes to the vitality and dynamism of the healthcare market, ensuring that companies have the financial resources to bring transformative solutions to market efficiently.
“Perceptive Capital Solutions, Inc. trades at a P/E of 157.9 (premium valuation) with modest ROE of 1.0%.”
Ask for details →Perceptive Capital Solutions, Inc. (ticker: PCSC) is a company listed on NASDAQ in the Financial Services sector (Shell Companies). Market cap is $132M.
The current price is $11.95 with a P/E ratio of 157.92x and P/B of 1.52x.
ROE is 0.97%.